Department of Clinical Research, University of Bern, Murtenstrasse, 35, 3010 Bern, Switzerland.
J Mol Cell Cardiol. 2010 Jan;48(1):2-11. doi: 10.1016/j.yjmcc.2009.08.025. Epub 2009 Sep 8.
The cardiac voltage-gated Na(+) channel Na(v)1.5 generates the cardiac Na(+) current (INa). Mutations in SCN5A, the gene encoding Na(v)1.5, have been linked to many cardiac phenotypes, including the congenital and acquired long QT syndrome, Brugada syndrome, conduction slowing, sick sinus syndrome, atrial fibrillation, and dilated cardiomyopathy. The mutations in SCN5A define a sub-group of Na(v)1.5/SCN5A-related phenotypes among cardiac genetic channelopathies. Several research groups have proposed that Na(v)1.5 may be part of multi-protein complexes composed of Na(v)1.5-interacting proteins which regulate channel expression and function. The genes encoding these regulatory proteins have also been found to be mutated in patients with inherited forms of cardiac arrhythmias. The proteins that associate with Na(v)1.5 may be classified as (1) anchoring/adaptor proteins, (2) enzymes interacting with and modifying the channel, and (3) proteins modulating the biophysical properties of Na(v)1.5 upon binding. The aim of this article is to review these Na(v)1.5 partner proteins and to discuss how they may regulate the channel's biology and function. These recent investigations have revealed that the expression level, cellular localization, and activity of Na(v)1.5 are finely regulated by complex molecular and cellular mechanisms that we are only beginning to understand.
心脏电压门控钠离子通道 Na(v)1.5 产生心脏钠离子电流 (INa)。SCN5A 基因编码 Na(v)1.5 的突变与许多心脏表型有关,包括先天性和获得性长 QT 综合征、Brugada 综合征、传导减慢、病态窦房结综合征、心房颤动和扩张型心肌病。SCN5A 中的突变定义了心脏遗传通道病中 Na(v)1.5/SCN5A 相关表型的一个亚组。几个研究小组提出,Na(v)1.5 可能是由与 Na(v)1.5 相互作用的调节蛋白组成的多蛋白复合物的一部分,这些调节蛋白调节通道的表达和功能。编码这些调节蛋白的基因也在遗传性心律失常患者中发现发生突变。与 Na(v)1.5 相关的蛋白可分为 (1) 锚定/衔接蛋白,(2) 与通道相互作用并修饰通道的酶,和 (3) 结合后调节 Na(v)1.5 生物物理特性的蛋白。本文的目的是综述这些 Na(v)1.5 伴侣蛋白,并讨论它们如何调节通道的生物学和功能。这些最近的研究表明,Na(v)1.5 的表达水平、细胞定位和活性受到复杂的分子和细胞机制的精细调节,而我们才刚刚开始理解这些机制。